JPH059406B2 - - Google Patents
Info
- Publication number
- JPH059406B2 JPH059406B2 JP62038138A JP3813887A JPH059406B2 JP H059406 B2 JPH059406 B2 JP H059406B2 JP 62038138 A JP62038138 A JP 62038138A JP 3813887 A JP3813887 A JP 3813887A JP H059406 B2 JPH059406 B2 JP H059406B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- siribum
- marianum
- fruit
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000284 extract Substances 0.000 claims description 39
- 239000000203 mixture Substances 0.000 claims description 28
- 235000013399 edible fruits Nutrition 0.000 claims description 17
- 239000002537 cosmetic Substances 0.000 claims description 15
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 5
- 229940087168 alpha tocopherol Drugs 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- 230000009759 skin aging Effects 0.000 claims description 5
- 229960000984 tocofersolan Drugs 0.000 claims description 5
- 235000004835 α-tocopherol Nutrition 0.000 claims description 5
- 239000002076 α-tocopherol Substances 0.000 claims description 5
- 239000012675 alcoholic extract Substances 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 150000003254 radicals Chemical class 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 9
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- -1 Superoxide radicals Chemical class 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- CYGIJEJDYJOUAN-UHFFFAOYSA-N Isosilychristin Natural products C1=C(O)C(OC)=CC(C2C3C=C(C4C(C3=O)(O)OCC42)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- MZBGBHVFCYCYLX-UHFFFAOYSA-N Silydianin Natural products COc1cc(ccc1O)C2C3COC4(O)C3C=C(C5Oc6cc(O)cc(O)c6C(=O)C5O)C2C4=O MZBGBHVFCYCYLX-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- XNRNNGPBEPRNAR-UHFFFAOYSA-N Thromboxane B2 Natural products CCCCCC(O)C=CC1OC(O)CC(O)C1CC=CCCCC(O)=O XNRNNGPBEPRNAR-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000032677 cell aging Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000006479 redox reaction Methods 0.000 description 2
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- XNRNNGPBEPRNAR-JQBLCGNGSA-N thromboxane B2 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1OC(O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O XNRNNGPBEPRNAR-JQBLCGNGSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Natural products CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- ZNHVWPKMFKADKW-LQWMCKPYSA-N 12(S)-HETE Chemical compound CCCCC\C=C/C[C@H](O)\C=C\C=C/C\C=C/CCCC(O)=O ZNHVWPKMFKADKW-LQWMCKPYSA-N 0.000 description 1
- ZNHVWPKMFKADKW-ZYBDYUKJSA-N 12-HETE Natural products CCCCC\C=C/C[C@@H](O)\C=C\C=C/C\C=C/CCCC(O)=O ZNHVWPKMFKADKW-ZYBDYUKJSA-N 0.000 description 1
- KUKJHGXXZWHSBG-WBGSEQOASA-N 12S-HHTrE Chemical compound CCCCC[C@H](O)\C=C\C=C\C\C=C/CCCC(O)=O KUKJHGXXZWHSBG-WBGSEQOASA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000320316 Carduus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- CRPGUMMYQABYES-HFRGRHLUSA-N Silandrin Natural products O(C)c1c(O)ccc([C@@H]2[C@H](CO)Oc3c(O2)ccc([C@@H]2Oc4c(c(O)cc(O)c4)C(=O)C2)c3)c1 CRPGUMMYQABYES-HFRGRHLUSA-N 0.000 description 1
- VLGROHBNWZUINI-UHFFFAOYSA-N Silybin Natural products COc1cc(ccc1O)C2OC3C=C(C=CC3OC2CO)C4Oc5cc(O)cc(O)c5C(=O)C4O VLGROHBNWZUINI-UHFFFAOYSA-N 0.000 description 1
- 244000272459 Silybum marianum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- RIAZZJBPJQWPIS-UHFFFAOYSA-N Silychristin Natural products COc1cc(ccc1O)C2OC3C(C=C(C=C3O)C4Oc5cc(O)cc(O)c5C(=O)C4O)C2CO RIAZZJBPJQWPIS-UHFFFAOYSA-N 0.000 description 1
- YBGWTZSEYYMFJI-AXUSBXICSA-N Silymonin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@H]3C=C([C@@H]4[C@@](C3=O)(O)OC[C@@H]42)[C@H]2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 YBGWTZSEYYMFJI-AXUSBXICSA-N 0.000 description 1
- LNLXUVRWFZAUFM-XLXRPKQLSA-N Silymonin Natural products O(C)c1c(O)ccc([C@H]2[C@@H]3C(=O)[C@]4(O)OC[C@H]2[C@@H]4C=C3[C@H]2Oc3c(c(O)cc(O)c3)C(=O)C2)c1 LNLXUVRWFZAUFM-XLXRPKQLSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940031955 anhydrous lanolin Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical group 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- CRPGUMMYQABYES-DNVKUUNQSA-N silandrin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC(=CC=C3O2)[C@H]2OC3=CC(O)=CC(O)=C3C(=O)C2)CO)=C1 CRPGUMMYQABYES-DNVKUUNQSA-N 0.000 description 1
- 229940043175 silybin Drugs 0.000 description 1
- 235000014899 silybin Nutrition 0.000 description 1
- BMLIIPOXVWESJG-LMBCONBSSA-N silychristin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@@H](C3=C(C(=CC(=C3)[C@@H]3[C@H](C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 BMLIIPOXVWESJG-LMBCONBSSA-N 0.000 description 1
- BMLIIPOXVWESJG-UHFFFAOYSA-N silychristin A Natural products C1=C(O)C(OC)=CC(C2C(C3=C(C(=CC(=C3)C3C(C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 BMLIIPOXVWESJG-UHFFFAOYSA-N 0.000 description 1
- CYGIJEJDYJOUAN-JSGXPVSSSA-N silydianin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@H]3C=C([C@@H]4[C@@](C3=O)(O)OC[C@@H]42)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-JSGXPVSSSA-N 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Description
本発明は皮膚の老化に抵抗する新規の化粧料組
成物に関する。本発明は特にはシリブム・マリア
ヌム(Silybum Marianum)の果実の抽出物を
活性成分として含有する化粧料組成物に関する。
シリブム・マリアヌムL.(Gaertn.)またはカル
ドウス・マリアヌム(Carduus Marianum)L.
の果実の抽出物は、シリビーン(Silybine)の重
合によつて得られるシリビン(Silybin)、シリデ
アニン(Silydianin)、シランドリン
(Silandrin)、シリクリスチン(Silychristin)、
シリモニン(Silymonin)、シリビノマー
(Silybinomer)を他の中に含むフラボノリグナ
ンに豊む混合物である。前記の成分は各種のポリ
フエノール例えばタキシホロールおよび他の成分
例えばデヒドロジコニフエリリツクアルコールに
よつて抽出物中で安定化される。
シリブム・マリアヌムの果実の抽出物は、
Wagner等の「Arzneim Forsch」1:8688,
1968に記載されているように溶媒例えばメタノー
ル、エタノールまたはアセトンによつて脂質を除
去した果実からの抽出によつて得ることができ
る。脂質の除去物は、非極性溶媒例えば四塩化炭
素または石油エーテルを使用することによつて得
ることができる。
前記の植物およびその活性成分は肝臓を保護す
る活性が知られており、この目的で従来から医薬
中で使用されてきた。
本発明者は、シリブム・マリアヌムの果実の抽
出物がラジカル(遊離基)抑制活性をもつこと、
およびシリブム・マリアヌムの果実の抽出物0.01
〜1重量%特に0.1〜0.5重量%を含有する局所組
成物が、皮膚の老化に部分的に関係するフリーラ
ジカルの劣化作用に抵抗することができることを
見出した。
フリーラジカルは、細胞の一生涯で非常に少量
が通常生成される。それらは、紫外線および可視
光線スペクトル内の輻射線の作用によつて生成さ
れることがある。皮膚は、それが直接露出されて
いるので、前記の生成方式によつて特に影響を受
ける。しかしながら、フリーラジカルは、特に生
理学的酸化−還元反応において生成される。こう
して生成されたラジカルは、それらを破壊するこ
とのできる酵素系によつて通常除去される。しか
しながら、過剰のラジカル生成または不完全な解
毒機構の結果として、前記の酵素系の負担が重す
ぎる場合には、ラジカルが細胞成分と反応してそ
れらを劣化させることになる。
フリーラジカルの優先的なターゲツトである細
胞成分は、機能上非常に重要なものである。これ
らの成分は、主に、細胞膜を形成するホスホリピ
ドの組成の一部分を形成する多不飽和脂肪酸であ
る。ラジカルが脂肪酸を攻撃すると、組織破壊が
膜全体に拡がつて、その機能特に表皮内のバリヤ
ーとしての役割(これは皮膚の正確な水和を保証
する)を妨害する。
タンパク質例えば酵素タンパク質並びに構造タ
ンパク質例えばコラーゲンおよびエラスチン(上
皮の必須成分である)もフリーラジカルのターゲ
ツトである。最後に、核酸例えばDNA(遺伝コー
ドのキヤリアー)はフリーラジカルの変性作用に
特に感受性が高い。それらの劣化は、たとえ極微
であつても長年に亘つて続くので、細胞の老化に
部分的に関連する回復不能の生化学的損害をもた
らす。
シリブム・マリアヌムの果実の抽出物は、その
ラジカル抑制活性により、皮膚の老化速度を遅く
することができる。
従つて、本発明は活性成分としてシリブム・マ
リアヌムの果実の抽出物を乾燥抽出物濃度0.01〜
1重量%有利には0.1〜0.5重量%で含有する、皮
膚の老化に抵抗する化粧料組成物に関する。
本発明者は、α−トコフエロール0.01〜0.5重
量%を前記組成物に加えることにより、皮膚の老
化に対する効果を増加することができることも見
出した。α−トコフエロールはシリブム・マリア
ヌムの果実の抽出物中に既に存在しているが低濃
度である点に注意されたい。
以下に、本発明で使用する活性成分のラジカル
抑制活性に関する研究を示す。
以下の研究で使用した組成物は、脂質を除去し
てあるシリブム・マリアヌムの果実のエタノール
抽出物のポリエチレングリコール400中の溶液
(乾燥抽出物含量50g/)であつた。この溶液
を、以下、SM抽出物と称する。
(1) 超酸化物ラジカルアニオンに対するラジカル
抑制活性
超酸化物ラジカルアニオン(O2 -)の形成は、
酸素のその他の反応性種の生成およびその後の有
機基の生成において重要な工程である。
酵素例えばキサンチンオキシダーゼによつて触
媒される多数の酸化還元反応によつて超酸化物ラ
ジカルを生成する。
SM抽出物の保護作用は、チトクロームC(そ
の変換を分光光度法により550nmで測定する)の
存在下で試験管内の前記酵素系によつて発生する
超酸化物アニオンに関して示す。
結果を第表に示す。
その結果が示すところによれば、SM抽出物は
超酸化物アニオンを捕捉することにより、チトク
ロームCの変換を抑制する。
The present invention relates to new cosmetic compositions that resist skin aging. The invention particularly relates to cosmetic compositions containing as active ingredient an extract of the fruit of Silybum Marianum. Siribum marianum L. (Gaertn.) or Carduus Marianum L.
The fruit extract contains Silybin, Silydianin, Silandrin, Silychristin, which is obtained by polymerization of Silybine.
Silymonin is a flavonolignan-rich mixture containing Silybinomer among others. The components mentioned above are stabilized in the extract by various polyphenols such as taxiphorol and other components such as dehydrodiconiferous alcohol. Siribum marianum fruit extract is
Wagner et al. “Arzneim Forsch” 1:8688,
It can be obtained by extraction from delipidated fruit with a solvent such as methanol, ethanol or acetone as described in J.D. 1968. Lipid removal can be obtained by using non-polar solvents such as carbon tetrachloride or petroleum ether. The above-mentioned plants and their active components are known for their liver-protecting activity and have traditionally been used in medicine for this purpose. The present inventor has discovered that the extract of Siribum marianum fruit has radical (free radical) inhibiting activity;
and siribum marianum fruit extract 0.01
It has been found that topical compositions containing ~1% by weight, especially 0.1-0.5% by weight, are able to resist the degrading effects of free radicals, which are partly related to skin aging. Free radicals are normally produced in very small amounts during the lifetime of a cell. They may be produced by the action of radiation in the ultraviolet and visible light spectra. The skin is particularly affected by the aforementioned production methods since it is directly exposed. However, free radicals are generated especially in physiological oxidation-reduction reactions. The radicals thus generated are usually removed by enzyme systems capable of destroying them. However, if the enzymatic system is too taxed, as a result of excessive radical production or incomplete detoxification mechanisms, the radicals will react with cellular components and degrade them. The cellular components that are the preferential targets of free radicals are of great functional importance. These components are primarily polyunsaturated fatty acids that form part of the composition of the phospholipids that form cell membranes. When radicals attack fatty acids, tissue destruction spreads throughout the membrane, interfering with its function, especially its role as a barrier within the epidermis, which ensures the correct hydration of the skin. Proteins such as enzyme proteins and structural proteins such as collagen and elastin, which are essential components of the epithelium, are also targets of free radicals. Finally, nucleic acids such as DNA (the carrier of the genetic code) are particularly susceptible to the degenerative effects of free radicals. Their deterioration, even minimal, continues over many years, resulting in irreversible biochemical damage that is partly related to cellular aging. Siribum marianum fruit extract can slow down the rate of skin aging due to its radical inhibiting activity. Therefore, the present invention uses the extract of Siribum marianum fruit as an active ingredient at a dry extract concentration of 0.01 to 0.01.
1% by weight, preferably from 0.1 to 0.5% by weight, for cosmetic compositions that resist skin aging. The inventor has also found that by adding 0.01 to 0.5% by weight of α-tocopherol to the composition, the effect on skin aging can be increased. It should be noted that α-tocopherol is already present in the extract of Siribum marianum fruit, but at low concentrations. Below, research on the radical inhibiting activity of the active ingredient used in the present invention will be shown. The composition used in the following studies was a solution in polyethylene glycol 400 (dry extract content 50 g/) of the ethanolic extract of Siribum marianum fruit, which had been delipidized. This solution is hereinafter referred to as SM extract. (1) Radical suppression activity against superoxide radical anions The formation of superoxide radical anions (O 2 - )
It is an important step in the production of other reactive species of oxygen and the subsequent production of organic groups. Superoxide radicals are produced by a number of redox reactions catalyzed by enzymes such as xanthine oxidase. The protective effect of the SM extract is demonstrated with respect to the superoxide anion generated by the enzyme system in vitro in the presence of cytochrome C (the conversion of which is measured spectrophotometrically at 550 nm). The results are shown in Table 1. The results show that SM extract suppresses the conversion of cytochrome C by scavenging superoxide anions.
【表】
(2) 多不飽和脂肪酸の過酸化の抑制(Bonne等、
1985,Annals of Allergy,54,158−160)
血小板は、フリーラジカルの生成およびそれを
細胞環境内で捕捉することのできる生成物の研究
に非常に有用なモデルである。実際、血小板は、
不飽和脂肪酸の過酸化を起こす酵素に特に富んで
いる。これらの反応は、ラジカル生成によつて開
始され、14Cでラベルした脂肪酸例えばアラキド
ン酸から形成される代謝産物のクロマトグラフイ
ー分離によつて容易に測定することができる。前
記のものは、代謝されて主にトロンボキサンB2
(TxB2)、ヒドロキシヘプタデカトリエン酸+マ
ロニルジアルデヒド(HHT+MDA)、およびヒ
ドロキシ−12−エイコサテトラエン酸(12−
HETE)となる。これらの前駆体は不安定な過
酸化物である。SM抽出物は、SM抽出物濃度0.10
〜0.25%(乾燥抽出物として計算)において細胞
それ自体の内で過酸化物のフリーラジカル生成を
防止することにより前記の代謝産物の生成を抑制
する。
結果を第表に示す。[Table] (2) Inhibition of peroxidation of polyunsaturated fatty acids (Bonne et al.
(1985, Annals of Allergy, 54, 158-160) Platelets are a very useful model for the study of free radical production and the products that can scavenge it within the cellular environment. In fact, platelets are
It is especially rich in enzymes that cause peroxidation of unsaturated fatty acids. These reactions are initiated by radical production and can be easily measured by chromatographic separation of metabolites formed from 14C-labeled fatty acids such as arachidonic acid. The above is metabolized mainly into thromboxane B2
(TxB2), hydroxyheptadecatrienoic acid + malonyl dialdehyde (HHT + MDA), and hydroxy-12-eicosatetraenoic acid (12-
HETE). These precursors are unstable peroxides. SM extract has an SM extract concentration of 0.10
~0.25% (calculated as dry extract) suppresses the production of the above-mentioned metabolites by preventing peroxide free radical production within the cells themselves. The results are shown in Table 1.
【表】【table】
【表】
(3) 皮膚中でのマロニルジアルデヒド(MDA)
生成の抑制
フリーラジカルが老化過程の原因であるとする
ことのできる細胞老化の徴候の1つは組織内にお
けるリポフシンの蓄積である。これらの顔料は、
脂質のフリーラジカル分解によつて生成されるマ
ロニルジアルデヒド(MDA)と第1アミンとの
反応から得られるシツフ塩基である。
この過程に関する保護効果を以下の試験(第
表)に示す。その試験において、化粧料用賦形剤
中に5%に希釈し、毛のないマウスの皮膚に塗布
すると、SM抽出物は、紫外線照射によつて誘発
されるMDAの形成を皮膚内において抑制する。
体重25〜30gの毛のないマウスを5匹ずつの群
に分け、表に記載のとおりに処理する。300nmに
おける紫外線照射強度は0.3J/cm2である。
照射を9時間後に止め、背側の皮膚を取り、秤
量し、そして緩衝化食塩溶液中でホモジナイズす
る。ホモジネートを遠心分離し、上清中のMDA
を、チオバルビツール酸との反応後に分光光度法
で測定する。[Table] (3) Malonyldialdehyde (MDA) in the skin
Inhibition of Production One of the signs of cellular aging in which free radicals can be attributed to the aging process is the accumulation of lipofusin in tissues. These pigments are
Schiff bases are obtained from the reaction of malonyl dialdehyde (MDA), produced by free radical decomposition of lipids, with primary amines. The protective effect regarding this process is shown in the following tests (Table). In that study, when diluted to 5% in a cosmetic excipient and applied to the skin of hairless mice, SM extract inhibited the formation of MDA in the skin induced by UV radiation. . Hairless mice weighing 25-30 g are divided into groups of 5 and treated as described in the table. The ultraviolet irradiation intensity at 300 nm is 0.3 J/cm 2 . Irradiation is stopped after 9 hours and the dorsal skin is removed, weighed and homogenized in buffered saline solution. Centrifuge the homogenate and remove MDA from the supernatant.
is determined spectrophotometrically after reaction with thiobarbituric acid.
【表】
本発明の化粧料組成物は、適当な場合には、皮
膚に対して有利な性質をもつ任意の公知物質を含
有することもできる。それらの物質は例えばコラ
ーゲン、エラスチン、ヒアルロン酸、不飽和脂肪
酸と結合した脂質、湿潤剤(軟釈剤)、ビタミン
に富む抽出物、香水、保存剤、および着色剤であ
る。前記組成物は更に日光の照射スクリーンまた
はフイルターを含有することができる。
本発明の化粧料組成物は、化粧料において使用
される任意の剤型をとることができる。例えば、
ビンまたは管内のゲルまたはクリーム、ガラス製
またはプラスチツク製のビン内の、そして適当な
場合には分配ビンまたはアンプル内のローシヨン
または乳液である。
従つて、本発明は、特には皮膚用のクリーム、
ゲル、乳液またはローシヨンの形の化粧料組成物
に関し、そして更に特には、賦形剤を顔または首
部に塗布できるようにしてある化粧料組成物に関
する。
個々の具体的な化粧料の剤型には適当な賦形剤
が必要となる。これらの賦形剤は、必要とされる
すべての性質をもつことが必要である。例えば、
ステアリン酸グリセロール、プロピレングリコー
ル、ラノリン、グリセロール、セチルアルコー
ル、ポリオール、植物油、動物油、鉱油、ワツク
ス、湿潤剤、濃化剤、安定剤および乳化剤等の通
常使用されるものを挙げることができる。
前記の各種の形の化粧料は当業界で使用されて
いる方法によつて製造する。
本発明は、本発明による前記化粧料組成物を調
製するための濃厚組成物にも関し、それはシリブ
ム・マリアヌムの果実の抽出物1〜10重量%(乾
燥抽出物として)と有利にはα−トコフエロール
0.2〜2重量%とを含有する。この組成物は、化
粧料組成物にとつて適切な基剤中に配合すること
ができる。
前記の濃縮組成物の例としては、脂質を除去し
てあるシリブム・マリアヌムの果実のアルコール
抽出物のポリエチレングリコール溶液、例えば乾
燥抽出物5重量%を含有する前記SM抽出物を挙
げることができる。前記組成物の他の例として
は、シリブム・マリアヌムの果実の抽出物5重量
%とα−トコフエロール1重量%とをポリエチレ
ングリコール400中に含むSMT抽出物である。
化粧料組成物の例を以下に挙げる(重量部)。
(1) O/Wクリーム
・ ステアリン酸グリセロール 5
・ 麦芽油 10
・ SM抽出物またはSMT抽出物 2〜10
・ プロピレングリコール 3
・ カルボキシビニルポリマー 0.5
・ トリエタノールアミン 0.5
・ 芳香族組成物 適量
・ 保存剤 適量
・ 水 100にする量
(2) O/Wミルク
・ オレイルアルコールポリエトキシエーテルホ
スフエート 2
・ セチルアルコール 0.5
・ 無水ラノリン 0.5
・ 液体状シリコーン 1
・ 麦芽油 2
・ ステアリン酸 3
・ トリエタノールアミン 0.5
・ SM抽出物またはSMT抽出物 2〜6
・ ケイ酸マグネシウムアルミニウム 0.5
・ 芳香族組成物 適量
・ 保存剤 適量
・ 水 適量
(3) 水性−アルコール系ローシヨン
・ セチルアルコール 0.5
・ ステアリン酸 5
・ グリセロール 2
・ SM抽出物またはSMT抽出物 3
・ アルギン酸ナトリウム 0.3
・ トリエタノールアミン 0.5
・ 94°アルコール 5
・ 水 83.7
(4) アルコール系ヒドロゲル
・ 40°アルコール 95
・ トリエチルアミン 1.5
・ EDTA 0.05
・ SM抽出物またはSMT抽出物 5
・ Carbopol 940 1.5
(5) グリセリド化ヒドロゲル
・ アルギン酸ナトリウム 8
・ グリセロール 25
・ ボラツクス(15%)のグリセロール溶液 20
・ SM抽出物またはSMT抽出物 5
・ チモール 2
・ 水 45[Table] The cosmetic compositions of the invention can also contain, if appropriate, any known substances that have beneficial properties for the skin. These substances are, for example, collagen, elastin, hyaluronic acid, lipids combined with unsaturated fatty acids, humectants (softeners), vitamin-rich extracts, perfumes, preservatives, and colorants. The composition may further contain a sunlight exposure screen or filter. The cosmetic composition of the present invention can take any form used in cosmetics. for example,
Gels or creams in bottles or tubes, lotions or emulsions in glass or plastic bottles and, where appropriate, in dispensing bottles or ampoules. Therefore, the invention particularly relates to creams for the skin,
The present invention relates to cosmetic compositions in the form of gels, emulsions or lotions, and more particularly to cosmetic compositions in which excipients are adapted to be applied to the face or neck. Appropriate excipients are required for each specific cosmetic formulation. These excipients need to have all the required properties. for example,
Mention may be made of commonly used agents such as glycerol stearate, propylene glycol, lanolin, glycerol, cetyl alcohol, polyols, vegetable oils, animal oils, mineral oils, waxes, wetting agents, thickening agents, stabilizers and emulsifiers. The various forms of cosmetics described above are manufactured by methods used in the art. The invention also relates to a concentrate composition for preparing the cosmetic composition according to the invention, which comprises from 1 to 10% by weight (as dry extract) of the extract of the fruit of Siribum marianum and advantageously α- Tocopherol
0.2 to 2% by weight. This composition can be formulated into a suitable base for cosmetic compositions. As an example of such a concentrated composition, mention may be made of a polyethylene glycol solution of an alcoholic extract of Siribum marianum fruit from which lipids have been removed, such as the aforementioned SM extract containing 5% by weight of dry extract. Another example of such a composition is an SMT extract comprising 5% by weight of Siribum marianum fruit extract and 1% by weight of α-tocopherol in polyethylene glycol 400. Examples of cosmetic compositions are listed below (parts by weight). (1) O/W cream・Glycerol stearate 5・Mat oil 10・SM extract or SMT extract 2~10・Propylene glycol 3・Carboxyvinyl polymer 0.5・Triethanolamine 0.5・Aromatic composition Appropriate amount・Preservative Appropriate amount - Water to make 100 (2) O/W milk - Oleyl alcohol polyethoxy ether phosphate 2 - Cetyl alcohol 0.5 - Anhydrous lanolin 0.5 - Liquid silicone 1 - Malt oil 2 - Stearic acid 3 - Triethanolamine 0.5 - SM extract or SMT extract 2 to 6 ・ Magnesium aluminum silicate 0.5 ・ Aromatic composition appropriate amount ・ Preservative appropriate amount ・ Water appropriate amount (3) Aqueous-alcoholic lotion ・ Cetyl alcohol 0.5 ・ Stearic acid 5 ・ Glycerol 2 ・ SM Extract or SMT extract 3 - Sodium alginate 0.3 - Triethanolamine 0.5 - 94° alcohol 5 - Water 83.7 (4) Alcohol-based hydrogel - 40° alcohol 95 - Triethylamine 1.5 - EDTA 0.05 - SM extract or SMT extract 5・ Carbopol 940 1.5 (5) Glyceridated hydrogel ・ Sodium alginate 8 ・ Glycerol 25 ・ Borax (15%) in glycerol 20 ・ SM extract or SMT extract 5 ・ Thymol 2 ・ Water 45
Claims (1)
の抽出物を乾燥抽出物濃度0.01〜1重量%で含有
する、皮膚の老化を防止する化粧料組成物。 2 シリブム・マリアヌムの果実の抽出物の乾燥
抽出物として計算して0.1〜0.5重量%を含有する
特許請求の範囲第1項記載の組成物。 3 シリブム・マリアヌムの果実のアルコール抽
出物を活性成分として含有する特許請求の範囲第
1項または第2項記載の組成物。 4 脂質を除去してあるシリブム・マリアヌムの
果実のアルコール抽出物のポリエチレングリコー
ル溶液を含有する特許請求の範囲第3項記載の組
成物。 5 α−トコフエロール0.1〜0.2重量%を含有す
る特許請求の範囲第1項から第4項までのいずれ
か1項に記載の組成物。[Scope of Claims] 1. A cosmetic composition for preventing skin aging, which contains an extract of Siribum marianum fruit as an active ingredient at a dry extract concentration of 0.01 to 1% by weight. 2. A composition according to claim 1, containing from 0.1 to 0.5% by weight, calculated as dry extract, of the fruit extract of Siribum marianum. 3. The composition according to claim 1 or 2, which contains an alcoholic extract of Siribum marianum fruit as an active ingredient. 4. The composition according to claim 3, comprising a polyethylene glycol solution of an alcoholic extract of Siribum marianum fruit from which lipids have been removed. 5. The composition according to any one of claims 1 to 4, containing 0.1 to 0.2% by weight of α-tocopherol.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8602889 | 1986-02-24 | ||
FR8602889A FR2594691B1 (en) | 1986-02-24 | 1986-02-24 | NEW COSMETIC PREPARATIONS CONTAINING EXTRACT OF SILYBUM MARIANUM FRUITS |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62223106A JPS62223106A (en) | 1987-10-01 |
JPH059406B2 true JPH059406B2 (en) | 1993-02-04 |
Family
ID=9332669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62038138A Granted JPS62223106A (en) | 1986-02-24 | 1987-02-23 | Cosmetic composition and prevention for skin senescence |
Country Status (7)
Country | Link |
---|---|
US (1) | US4749573A (en) |
EP (1) | EP0236218B1 (en) |
JP (1) | JPS62223106A (en) |
CA (1) | CA1334005C (en) |
DE (1) | DE3770025D1 (en) |
FR (1) | FR2594691B1 (en) |
ZA (1) | ZA871212B (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2609630B1 (en) * | 1987-01-19 | 1991-01-04 | Rochas Parfums | NOVEL COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING AN EXTRACT OF SILYBUM MARIANUM FRUITS RICH IN SILYMARINE ASSOCIATED WITH ESSENTIAL FATTY ACIDS |
FR2613618B2 (en) * | 1987-04-10 | 1991-03-22 | Rochas Parfums | NOVEL COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING AN EXTRACT OF SILYBUM MARIANUM FRUITS ASSOCIATED WITH ESSENTIAL FATTY ACIDS |
ES2032574T3 (en) * | 1987-01-19 | 1993-02-16 | Parfums Rochas | NEW COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING AN EXTRACT OF FRUITS OF "SILYBUM MARIANUM", RICH IN SILIMARINE, ASSOCIATED WITH ESSENTIAL FATTY ACIDS. (RESERVATION OF ART. 167.2 CPE). |
IT1222012B (en) * | 1987-07-10 | 1990-08-31 | Indena Spa | PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING COMPLEX FLAVONOLIGNANS WITH PHOSPHOLIPIDS |
FR2666226B1 (en) * | 1990-08-30 | 1994-10-28 | Jean Noel Thorel | PROTECTIVE SKIN COMPOSITION. |
DE4101122A1 (en) * | 1991-01-16 | 1992-07-23 | Betrix Cosmetic Gmbh & Co | COSMETIC OR PHARMACEUTICAL AGENT |
IT1253431B (en) * | 1991-12-02 | 1995-08-08 | Valetudo S R L | PHARMACEUTICAL PREPARATIONS FOR TOPICAL USE FOR THE TREATMENT OF PSORIASIS AND ATOPIC DERMATITIS |
US5648377A (en) * | 1993-12-21 | 1997-07-15 | Indena S.P.A. | Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
US6379714B1 (en) | 1995-04-14 | 2002-04-30 | Pharmaprint, Inc. | Pharmaceutical grade botanical drugs |
AU5377499A (en) * | 1999-08-26 | 2001-03-19 | Jean Julia | Cosmetic use of cynara cardunculus of silybum marianum oils |
FR2809008B1 (en) * | 2000-05-19 | 2006-07-28 | Sarl I De Zica | COSMETIC COMPOSITION COMPRISING CERAMIDES ASSOCIATED WITH SILYMARIN |
DE10041272A1 (en) * | 2000-08-23 | 2002-03-07 | Beiersdorf Ag | Substances for inducing and intensifying the tanning mechanisms of the skin and cosmetic or dermatological formulations containing the same |
FR2825273B1 (en) * | 2001-05-29 | 2006-11-24 | Oreal | COMPOSITION FOR THE TREATMENT OF SKIN SIGNS OF AGING |
DE10225772A1 (en) * | 2002-06-10 | 2003-12-24 | Beiersdorf Ag | Cosmetic or dermatological formulations for skin care after sunbathing or shaving |
JP3926711B2 (en) * | 2002-08-30 | 2007-06-06 | 株式会社ファンケル | Composition for preventing skin aging to prevent, prevent and improve flattening of the epidermis |
TWI256893B (en) * | 2003-03-25 | 2006-06-21 | Fancl Corp | Composition for promoting production of type I collagen and/or elastin |
DE102005000868A1 (en) * | 2004-10-15 | 2006-04-20 | Henkel Kgaa | Compositions with inhibitors of prostaglandin and / or leukotriene synthesis in combination with stimulants of the release of cutaneous neuromediators |
JP4033877B2 (en) | 2005-09-29 | 2008-01-16 | 株式会社ファンケル | Composition for promoting type I collagen production |
JP3914244B2 (en) * | 2005-10-03 | 2007-05-16 | 株式会社ファンケル | Abnormal protein removal composition |
DE102005048780A1 (en) * | 2005-10-10 | 2007-04-12 | Beiersdorf Ag | Hydrous cosmetic preparation with dissolved flavonolignans |
EP2066406A2 (en) * | 2006-09-19 | 2009-06-10 | Basf Se | Cosmetic preparations based on molecularly imprinted polymers |
JP2007056035A (en) * | 2006-10-19 | 2007-03-08 | Fancl Corp | Differentiation inhibiting agent for normal keratinized human epithelium cell |
US8815308B2 (en) | 2010-12-30 | 2014-08-26 | Mary Kay, Inc. | Multi-purpose cosmetic compositions |
TR201100629A2 (en) * | 2011-01-24 | 2011-07-21 | Boyut Diş Ti̇caret İnşaat Ve Madenci̇li̇k San.Ltd.Şti̇. | A biochemical plant protection product and plant growth regulator |
US8877259B2 (en) | 2012-02-09 | 2014-11-04 | Mary Kay Inc. | Cosmetic formulation |
US9289374B2 (en) * | 2014-04-23 | 2016-03-22 | Lifevantage Corporation | Topical compositions and methods for reducing oxidative stress |
FR3075037B1 (en) * | 2017-12-20 | 2020-07-17 | Pierre Fabre Dermo-Cosmetique | COMBINATION OF A RETINOIDE AND AN EXTRACT OF SILYBUM MARIANUM (L.) GAERTN |
EP4225266A1 (en) * | 2020-10-05 | 2023-08-16 | Clariant International Ltd | Compositions comprising silybum marianum extract as a senotherapeutic agent |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1923082C3 (en) * | 1969-05-06 | 1985-08-22 | Dr. Madaus & Co, 5000 Koeln | Process for the production of polyhydroxyphenylchromanones (Silymarin I-IV) and medicaments containing the polyhydroxyphenylchromanone (Silymarin I-IV = Silymarin I-IV group) mixture |
DE2017789A1 (en) * | 1970-04-09 | 1971-10-21 | Klosa, Josef, Dipl.-Chem. Dr.Rer. Nat., 1000 Berlin | Carduus marianus seed extraction and sily-marine isolation |
SU822824A1 (en) * | 1979-07-06 | 1981-04-23 | Московский Научно-Исследовательскийинститут Косметологии | Face skin cream |
DE3225688A1 (en) * | 1982-07-09 | 1984-01-12 | Suschnik Matthias Dr | Process for the isolation of silymarin from Silybum marianum |
JP3336427B2 (en) * | 1996-08-29 | 2002-10-21 | 日信工業株式会社 | Parking brake mechanism for vehicle disk brake and method of assembling bearings used for the parking brake mechanism |
-
1986
- 1986-02-24 FR FR8602889A patent/FR2594691B1/en not_active Expired - Lifetime
-
1987
- 1987-02-17 US US07/015,226 patent/US4749573A/en not_active Expired - Fee Related
- 1987-02-19 CA CA000530147A patent/CA1334005C/en not_active Expired - Fee Related
- 1987-02-19 ZA ZA871212A patent/ZA871212B/en unknown
- 1987-02-23 EP EP87400396A patent/EP0236218B1/en not_active Expired - Lifetime
- 1987-02-23 DE DE8787400396T patent/DE3770025D1/en not_active Expired - Lifetime
- 1987-02-23 JP JP62038138A patent/JPS62223106A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2594691A1 (en) | 1987-08-28 |
ZA871212B (en) | 1987-09-30 |
EP0236218B1 (en) | 1991-05-15 |
FR2594691B1 (en) | 1990-08-03 |
EP0236218A1 (en) | 1987-09-09 |
DE3770025D1 (en) | 1991-06-20 |
US4749573A (en) | 1988-06-07 |
CA1334005C (en) | 1995-01-17 |
JPS62223106A (en) | 1987-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH059406B2 (en) | ||
US4992264A (en) | Novel cosmetic compositions containing an extract of the aerial parts of Cichorium intybus L | |
DE69913035T9 (en) | Cosmetic composition with antiradical synergistic effect | |
EP1140006B1 (en) | Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis | |
JP2003113068A (en) | Skin cosmetic | |
JPH06227960A (en) | Melanin formation inhibitor and skin cosmetic | |
KR20170055172A (en) | Cosmetic Composition Comprising Extracts of Centipeda minima | |
KR100638053B1 (en) | Cosmetic composition for abirritating skin containing extract of rumex crispus as active ingredient | |
KR20150004963A (en) | Cosmetic Composition for the Skin Whitening Comprising the Lapachol | |
KR20080004353A (en) | Cosmetic composition containing an extract of limnocitrus littoralis | |
KR101416993B1 (en) | Anti-wrinkle cosmetic composition | |
KR102310366B1 (en) | Skin external composition for anti-aging comprising cyanidin-3-o-glucoside and natto gum | |
KR100453217B1 (en) | Skin whitener | |
RU2284191C2 (en) | Pharmaceutical and cosmetic compositions for skin protection from damages caused by solar irradiation | |
KR20210142296A (en) | Cosmetic composition for skin improvement containing phyto DNA extracted from aloe vera adventitious root | |
KR100787782B1 (en) | Cosmetic composition for reducing the skin irritation comprising the extract of nymphaea caerulea as active ingredient | |
KR20010018668A (en) | A cosmetic composition containing Cinnamomi Cortex extracts | |
FR2809003A1 (en) | The use of anthocyanins in cosmetic compositions to protect against pollution, especially toxic gases and ozone | |
KR20140076121A (en) | Cosmetics containing Eurycoma longifolia jack extracts and method manufacturing the same | |
KR102555418B1 (en) | Cosmetic composition for protecting skin comprising mixed extracts of androgrphis paniculta and selaginella tamaricina fermanated by bacillus subtillus j2k-351 strain | |
KR102335682B1 (en) | Cosmetic Composition For Moisturizing Skin Comprising Fermentative Extract of Equisetum giganteum | |
KR20010018663A (en) | A cosmetic composition containing Terminaliae Fructus extracts | |
US5135946A (en) | Use of 2,4 monofurfurylidene-sorbitol and its tetraalkyl derivatives in cosmetics and dermatology | |
JP6661292B2 (en) | Peroxidation inhibitors for lipids and cosmetics for scalp hair | |
KR20200020322A (en) | Cosmetic composition having anti oxidant, whitening, and anti aging activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |